1. Home
  2. News
  3. Beijing Tiantan Biological Products Corporation Limited
  4. Report for Q3 2024
More Beijing Tiantan Biological Products Corporation Limited news
Beijing Tiantan Biological Products Corporation LimitedSSE: 600161

Report for Q3 2024

Oct 26, 2024 · Issued by Beijing Tiantan Biological Products Corporation Limited via Shanghai Stock Exchange

Filed with SSE · Oct 26, 2024

On 6ix: 6ix.com/news/report-for-q3-2024-51

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Beijing Tiantan Biological Products Corporation Limited on 6ix

Earlier from Beijing Tiantan Biological Products

  • Announcement on the Progress of Chengdu Rongsheng Pharmaceuticals Co., Ltd. Acquiring 100% Equity of Wuhan Zhongyuan Ruide Biological Products Co., Ltd.Oct 22, 2024

Later from Beijing Tiantan Biological Products

  • Announcement on Convening the Q3 2024 Performance BriefingNov 1, 2024
  • Announcement on Obtaining Clinical Trial Summary Report by Affiliated EnterpriseNov 23, 2024
  • Announcement on Resignation of DirectorNov 26, 2024
  • Announcement on Resignation of Deputy General Manager and Secretary of the Board of DirectorsNov 29, 2024
  • Announcement on Resolutions of 17th Meeting of 9th Board of DirectorsDec 19, 2024
All Beijing Tiantan Biological Products news releases↗

Follow Beijing Tiantan Biological Products into a list and get an email when it puts out news.

Follow Beijing Tiantan Biological Products
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer